Accession Number: | 0001127602-22-012859 |
Date: | 2022-04-28 |
Issuer: | MODERNA, INC. (MRNA) |
Original Submission Date: |
BERENSON STEPHEN
C/O MODERNA, INC.
200 TECHNOLOGY SQUARE
CAMBRIDGE, MA 02139
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2022-04-28 | M | 703 | a | $0.00 | 20,801 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
RESTRICTED STOCK UNITS | 0.0 | 2022-04-28 | deemed execution date | M | 703 (d) | common stock 703 | $0.00 | 0 | direct | |||
STOCK OPTION (RIGHT TO BUY) | 142.52 | 2022-04-28 | deemed execution date | A | 4,061 (a) | common stock 4,061 | $142.52 | 4,061 | direct | |||
RESTRICTED STOCK UNITS | 0.0 | 2022-04-28 | deemed execution date | A | 670 (a) | common stock 670 | $0.00 | 670 | direct |
ID | footnote |
---|---|
f1 | restricted stock units convert into common stock on a one-for-one basis. |
f2 | the shares subject to this restricted stock unit award vested in full on april 28, 2022. |
f3 | this option will become fully vested and exercisable on the earlier of april 28, 2023, or moderna's next annual meeting of stockholders, subject to the recipient's continued service. |
f4 | the shares subject to this restricted stock unit award will vest in full on the earlier of april 28, 2023, or moderna's next annual meeting of stockholders, subject to the recipient's continued service. |